Can You Take Tessalon (Benzonatate) While Breastfeeding?

Alan Lucks | MD

Medically reviewed by Alan Lucks | MD , Alan Lucks MDPC Private Practice - New York on June 18th, 2026. Updated on June 18th, 2026

Key Takeaways

  • Limited safety data exists for benzonatate transfer into breast milk, requiring cautious use during breastfeeding

  • Safer alternative cough treatments are available for nursing mothers, including dextromethorphan and natural remedies

  • Healthcare provider consultation is essential before taking benzonatate while breastfeeding to assess individual risk-benefit ratio

  • Monitor nursing infants closely for signs of sedation or respiratory changes if benzonatate use becomes necessary

  • Risk-benefit analysis should weigh severity of maternal cough symptoms against potential infant exposure concerns

Understanding Benzonatate and Its Mechanism of Action

Benzonatate, commonly known by the brand name Tessalon Perles, is a non-narcotic cough suppressant that works differently from traditional opioid-based cough medications. This medication functions by numbing the stretch receptors in the lungs, throat, and respiratory passages that trigger the cough reflex. Unlike narcotic cough suppressants that work through the central nervous system, benzonatate provides localized action to reduce coughing episodes.

The medication is typically prescribed in 100mg or 200mg soft gel capsules, with adults usually taking 100-200mg three times daily as needed for cough relief. Treatment duration generally ranges from a few days to two weeks, depending on the underlying condition causing the persistent cough. Benzonatate begins working within 15-20 minutes of administration and provides cough suppression for up to eight hours.

For breastfeeding mothers dealing with persistent cough symptoms, understanding how medications like benzonatate might affect both maternal health and infant safety becomes particularly important. Similar medication safety considerations apply to other treatments, such as allergy medicine while breastfeeding and fever medication during breastfeeding, where nursing mothers must weigh benefits against potential risks.

Breastfeeding Safety Profile and Available Research

The safety profile of benzonatate during breastfeeding remains largely understudied, with limited clinical data available regarding its transfer into human breast milk. The medication carries an FDA pregnancy category C classification, meaning animal studies have shown adverse effects on developing fetuses, but adequate human studies are lacking. This classification extends concerns to the breastfeeding period, where similar data gaps exist.

Current medical literature provides minimal information about benzonatate concentrations in breast milk or its potential effects on nursing infants. The drug's molecular structure suggests it may have some degree of transfer into breast milk, but the extent and clinical significance remain unclear. This uncertainty places benzonatate in a category requiring careful risk-benefit assessment for breastfeeding mothers.

Pharmacological properties of benzonatate include its protein binding characteristics and metabolism pathway, which could influence milk transfer. The medication is metabolized in the liver and has a relatively short half-life, potentially limiting prolonged infant exposure. However, without specific lactation studies, healthcare providers must rely on theoretical considerations and clinical judgment when advising nursing mothers.

Potential Risks and Infant Monitoring Considerations

While specific adverse effects of benzonatate in nursing infants haven't been documented, theoretical concerns exist based on the medication's mechanism of action. The drug's ability to cause numbness and its potential central nervous system effects raise questions about possible infant sedation or respiratory changes, particularly in newborns who may be more sensitive to maternal medications.

Infants under three months of age may be at higher risk for medication-related complications due to immature liver metabolism and kidney function. These physiological differences could potentially lead to prolonged drug exposure if benzonatate transfers into breast milk. Premature infants or those with existing respiratory conditions may face additional concerns.

Nursing mothers who must take benzonatate should monitor their infants closely for signs of unusual drowsiness, feeding difficulties, or changes in breathing patterns. Any concerning symptoms warrant immediate pediatric evaluation. Just as with other medications, careful infant observation becomes essential when nursing mothers require medication treatment.

Alternative Treatment Options for Nursing Mothers

Several safer alternatives exist for breastfeeding mothers seeking cough relief. Dextromethorphan, found in many over-the-counter cough medications, has more established safety data during lactation, with minimal transfer into breast milk and no reported adverse effects in nursing infants. This makes it a preferred first-line option for many healthcare providers.

Non-pharmacological approaches can provide significant cough relief without medication concerns. These include staying well-hydrated, using humidifiers to moisten airways, consuming warm fluids like herbal teas, and using honey for its natural cough-suppressing properties. Throat lozenges and steam inhalation can also help soothe irritated respiratory passages.

Treatment Option

Safety During Breastfeeding

Effectiveness for Cough

Potential Infant Risks

Benzonatate

Limited data, use with caution

Highly effective for persistent cough

Unknown, theoretical concerns

Dextromethorphan

Well-studied, considered safe

Moderately effective

Minimal to none

Natural remedies

Generally safe

Variable effectiveness

Very low

Healthcare Provider Consultation and Decision-Making

The decision to use benzonatate while breastfeeding should always involve healthcare provider guidance, considering both maternal symptom severity and infant safety. Healthcare providers can assess individual risk factors, including infant age, health status, and feeding patterns, to make personalized recommendations about cough treatment options.

Important questions to discuss with your healthcare provider include the severity and duration of your cough, previous treatment responses, any underlying respiratory conditions, and your infant's age and health status. Your provider may recommend trying safer alternatives first or suggest timing strategies if benzonatate becomes necessary.

Coordination between your primary care provider and your baby's pediatrician ensures comprehensive care for both mother and infant. This collaborative approach helps identify the safest treatment options while maintaining effective symptom management. Modern healthcare technology, including platforms with 99.2% treatment plan alignment with board-certified physicians, can provide accessible guidance for nursing mothers navigating medication decisions.

Managing Overall Health During Breastfeeding

Beyond cough management, nursing mothers benefit from comprehensive health strategies that support both maternal well-being and infant safety. Maintaining good respiratory health through preventive measures can reduce the need for cough medications altogether. These strategies include practicing good hand hygiene, avoiding respiratory irritants, staying up-to-date with vaccinations, and managing underlying conditions that might predispose to respiratory symptoms. For nursing mothers requiring multiple medications or dealing with complex health conditions, establishing care with healthcare providers experienced in lactation medicine ensures optimal treatment decisions.

Frequently Asked Questions

Due to limited data on benzonatate in breast milk, specific timing recommendations aren't established. Peak blood levels occur within 15-20 minutes, but drug elimination varies. Consult your healthcare provider for personalized guidance on timing between doses and nursing sessions to ensure safety.

Watch for unusual drowsiness, difficulty feeding, changes in breathing patterns, or decreased alertness in your baby. While theoretical with benzonatate, any concerning changes in your infant's behavior warrant immediate pediatric evaluation and professional medical assessment.

Exclusive breastfeeding may increase concerns about medication transfer since your baby receives all nutrition through breast milk. Discuss safer alternatives with your healthcare provider, as other cough suppressants may be more appropriate for exclusively nursing mothers and infants.

Yes, dextromethorphan is considered safer during breastfeeding with minimal transfer into breast milk. Natural remedies like honey, warm fluids, and humidifiers can also provide effective cough relief without medication concerns for nursing mothers and their infants.

Pumping and dumping isn't typically recommended for benzonatate since limited data exists on its presence in breast milk. Instead, discuss timing strategies or alternative treatments with your healthcare provider to minimize any potential infant exposure and ensure safety.

The Bottom Line

While benzonatate can provide effective cough relief, limited research on its transfer into breast milk makes it a less ideal choice for nursing mothers. Safer alternatives exist, including dextromethorphan and natural remedies, that may better suit breastfeeding women. The decision to use benzonatate while nursing should involve careful consideration of the severity of your cough symptoms versus potential risks to your infant. Nursing mothers should always consult with a licensed clinician for new, worsening, or high-risk symptoms to ensure safe breastfeeding and maternal health.

Related Articles

Get women's health advice